India’s Patanjali Ayurved and the Dharampal Satyapal Group (DS Group) have agreed to acquire a controlling stake in Magma ...

Patanjali’s Renogrit effectively mitigates kidney damage caused by the cancer drug cisplatin, according to a study published ...

Haridwar: Inspired by Yog Rishi Swami Ramdev and evidence-based Ayurvedic medicine research conducted by scientists of ...

The 62nd All India Shastra Utsav will feature a grand recitation of scriptures and a Ganga Aarti at Har Ki Pauri, aiming to ...

India's insurance sector is undergoing significant changes with policy shifts and new alliances. Allianz SE has ended its JV ...

Jefferies expects Patanjali Foods to deliver high single-digit topline growth, coupled with margin expansion going ahead.

The study on Renogrit has already been downloaded 2,568 times, highlighting the increasing global interest in Ayurvedic ...

Baba Ramdev-led Patanjali Ayurved and DS Group to acquire a 98% stake in Magma General Insurance, marking a major foray into ...

Patanjal Foods' focus on distribution, premiumisation, and brand building will help the company deliver double-digit growth, ...

Overseas brokerage firm Jefferies has initiated coverage on as many as three companies including Waaree Energies, Sai Life ...

Patanjali Foods stock was trading at ₹1,736 on March 17. The stock has fallen over 4 per cent in over a month.

Patanjali has expanded both domestically and internationally through digital marketing and distribution partnerships.